Arkolith/Insider Trading/BBNX/Form 4

Feider Stephen

Chief Financial OfficerBeta Bionics, Inc. (BBNX) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$170K
Net Open-Market Flow
-$170K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)5K$5.10$25K171K
Jun 29, 2026Sell(S)5K$17.03$83K166K
Jun 26, 2026Option exercise(M)5K$5.10$25K171K
Jun 26, 2026Sell(S)5K$17.05$87K166K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)5K—$040K
Jun 26, 2026Option exercise(M)5K—$045K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002048588-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML